{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T21:12:18Z","timestamp":1789506738581,"version":"build-2803163510"},"reference-count":33,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMIR Res Protoc"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec sec-type=\"background\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The COVID-19 pandemic impacted over 620 million people, including approximately 9 million in Africa, and introduced uncertainties, especially regarding coinfection with tuberculosis (TB) or HIV. TB and HIV, both global epidemics, disproportionately affect low- and middle-income countries. Namibia and Botswana have reported high mortality rates due to TB and HIV, highlighting ongoing challenges.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"objective\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This paper outlines the protocol for a research study in Botswana and Namibia to address these uncertainties and enhance disease management for COVID-19, TB, and HIV, especially with coinfection. The central hypothesis is that TB or HIV coinfection increases the risk of adverse clinical, immunological, and virological COVID-19 outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"methods\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Core-NB is a prospective clinical cohort of patients with COVID-19 identified through facility-based surveillance. The objectives were to (1) characterize the early COVID-19 pandemic in conjunction with TB and HIV in clinical, epidemiological, virological, and immunological terms via a household transmission study; and (2) conduct targeted COVID-19 screening and testing in conjunction with TB and HIV case finding through a primary health care (PHC) facility surveillance study. For objective 1, participants were identified with reverse-transcription polymerase chain reaction (PCR) confirmation of COVID-19 at ministry of health\u2013designated laboratories in each country. For objective 2, PHC attendees were enrolled independent of the reason for attending.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"results\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Index participants and consenting household contacts received home visits, including an initial enrollment visit on day 1 (the day of COVID-19 diagnosis for the index patient) and 3 follow-up visits taking place within 28 days of enrollment. Additionally, there were telephone follow-ups 3 months after enrollment. Age, sex, race, occupation, income, and educational attainment were recorded using a standardized questionnaire for all participants. Three respiratory specimens were obtained from each participant: (1) nasopharyngeal swab (SARS-CoV-2 RNA extraction and PCR); (2) sputum (GeneXpert Ultra active TB testing); and (3) extra sputum (an additional sputum sample was collected in case the GeneXpert Ultra test was positive to use for culture and drug susceptibility testing). The study was funded in October 2021, with data collection starting in June 2022 and finalized in February 2024. The household component enrolled 66 index patients with COVID-19 and 144 household contacts. In total, 1556 participants were enrolled in the PHC clinic component. The primary outcome data analyses are ongoing and expected to be published in July 2026, with secondary outcomes published in December 2026.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"conclusions\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study will strengthen COVID-19, TB, and HIV diagnosis, surveillance, and control through (1) high-resolution surveillance and transmission data to establish guidelines and policies; (2) data to develop further interventions; (3) implementation of new technologies to improve care provision and boost the cooperation of stakeholders; (4) support for the development of skills and expertise in-country; and (5) contribution of evidence to build a regional network of expertise in the COVID-19, TB, and HIV coepidemics.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2196\/79438","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T20:40:07Z","timestamp":1784061607000},"page":"e79438-e79438","source":"Crossref","is-referenced-by-count":0,"title":["The Effect of Tuberculosis and HIV on the Epidemiological, Clinical, Virological, and Immunological Trajectory of COVID-19: Protocol for a Prospective Case-Ascertained and Surveillance Study"],"prefix":"10.2196","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-7495-2473","authenticated-orcid":false,"given":"Azaria","family":"Diergaardt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4253-8744","authenticated-orcid":false,"given":"Etuhole","family":"Iipumbu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6401-2872","authenticated-orcid":false,"given":"Sibongile","family":"Netha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-7170-5003","authenticated-orcid":false,"given":"Pieter","family":"Steenkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-3531-8492","authenticated-orcid":false,"given":"Libertina","family":"Shiweva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9905-9322","authenticated-orcid":false,"given":"Balladiah","family":"Kizito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2217-4322","authenticated-orcid":false,"given":"Gunar","family":"G\u00fcnther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4302-5606","authenticated-orcid":false,"given":"Emmanuel","family":"Nepolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6357-7999","authenticated-orcid":false,"given":"Tadesse","family":"Woldetsadik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6604-0684","authenticated-orcid":false,"given":"Stefan","family":"Niemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2033-0379","authenticated-orcid":false,"given":"Chawangwa","family":"Modongo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5927-284X","authenticated-orcid":false,"given":"Mareli","family":"Claassens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2026,9,15]]},"reference":[{"key":"R1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1104828","article-title":"The COVID-19, tuberculosis and HIV\/AIDS: M\u00e9nage \u00e0 Trois","volume":"14","author":"Udoakang","journal-title":"Front Immunol"},{"key":"R2","unstructured":"Novel coronavirus (COVID-19) open. World Health Organization. URL: https:\/\/www.who.int\/publications\/journals\/bulletin\/covid-19 [Accessed 23-01-2026]"},{"issue":"12","key":"R3","doi-asserted-by":"publisher","first-page":"2000256","DOI":"10.2807\/1560-7917.ES.2020.25.12.2000256","article-title":"Estimating the infection and case fatality ratio for coronavirus disease (COVID-19) using age-adjusted data from the outbreak on the Diamond Princess cruise ship, February 2020","volume":"25","author":"Russell","journal-title":"Euro Surveill"},{"issue":"7","key":"R4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003189","article-title":"Estimation of SARS-CoV-2 mortality during the early stages of an epidemic: a modeling study in Hubei, China, and six regions in Europe","volume":"17","author":"Hauser","journal-title":"PLoS Med"},{"key":"R5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2020.03.017","article-title":"Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis","volume":"94","author":"Yang","journal-title":"Int J Infect Dis"},{"issue":"12","key":"R6","doi-asserted-by":"publisher","first-page":"343","DOI":"10.15585\/mmwr.mm6912e2","article-title":"Severe outcomes among patients with coronavirus disease 2019 (COVID-19) - United States, February 12-March 16, 2020","volume":"69","author":"CDC COVID-19 Response Team","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"10","key":"R7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002152","article-title":"The global burden of latent tuberculosis infection: a re-estimation using mathematical modelling","volume":"13","author":"Houben","journal-title":"PLoS Med"},{"issue":"1","key":"R8","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2022.e12727","article-title":"Main modulators of COVID-19 epidemic in sub-Saharan Africa","volume":"9","author":"Zinsou","journal-title":"Heliyon"},{"key":"R9","unstructured":"Global tuberculosis report 2024. World Health Organization; 2024. URL: https:\/\/www.who.int\/teams\/global-programme-on-tuberculosis-and-lung-health\/tb-reports\/global-tuberculosis-report-2024 [Accessed 27-08-2026]"},{"issue":"12","key":"R10","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.4081\/jphia.2023.2094","article-title":"Effectiveness and impact of Covid-19 response and vaccination challenges in Namibia: a systematic review","volume":"14","author":"Niikondo","journal-title":"J Public Health Afr"},{"key":"R11","doi-asserted-by":"crossref","unstructured":"Chen Y Wang Y Fleming J et al. Active or latent tuberculosis increases susceptibility to COVID-19 and disease severity. medRxiv. Preprint posted online on Mar 16, 2020. [doi: 10.1101\/2020.03.10.20033795]","DOI":"10.1101\/2020.03.10.20033795"},{"key":"R12","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2021.06.007","article-title":"Tri-infection: tuberculosis, HIV, COVID-19 and the already strained South African health system","volume":"96","author":"Matatiele","journal-title":"Brain Behav Immun"},{"issue":"1","key":"R13","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/s41467-022-35689-1","article-title":"Effects of tuberculosis and\/or HIV-1 infection on COVID-19 presentation and immune response in Africa","volume":"14","author":"du Bruyn","journal-title":"Nat Commun"},{"issue":"1","key":"R14","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.4102\/phcfm.v17i1.4944","article-title":"Access to tuberculosis care in South Africa during the COVID-19 pandemic: a scoping review","volume":"17","author":"Appel","journal-title":"Afr J Prim Health Care Fam Med"},{"issue":"1","key":"R15","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-023-08004-6","article-title":"The clinical and epidemiological characteristics of a series of patients living with HIV admitted for COVID-19 in a district hospital","volume":"23","author":"Mnguni","journal-title":"BMC Infect Dis"},{"issue":"4","key":"R16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgph.0004471","article-title":"COVID-19, tuberculosis, and HIV triad: a prospective observational study in ambulatory patients in Kenya, Uganda, and South Africa","volume":"5","author":"Huerga","journal-title":"PLOS Glob Public Health"},{"key":"R17","unstructured":"Population and housing census 2011: administrative and technical report. Statistics Botswana; 2016. URL: https:\/\/www.statsbots.org.bw\/population-and-housing-census-2011-administrative-and-technical-report [Accessed 27-08-2026]"},{"key":"R18","unstructured":"Data catalog. National Data Archive. URL: https:\/\/microdata.nsanamibia.com\/index.php\/catalog\/central\/?page=1&ps=15 [Accessed 23-01-2026]"},{"issue":"4","key":"R19","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1097\/EDE.0b013e31825588b8","article-title":"Household transmission of 2009 pandemic influenza A (H1N1): a systematic review and meta-analysis","volume":"23","author":"Lau","journal-title":"Epidemiology"},{"issue":"23","key":"R20","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1056\/NEJMoa0911530","article-title":"Comparative epidemiology of pandemic and seasonal influenza A in households","volume":"362","author":"Cowling","journal-title":"N Engl J Med"},{"issue":"3","key":"R21","doi-asserted-by":"publisher","first-page":"1900655","DOI":"10.1183\/13993003.00655-2019","article-title":"The global prevalence of latent tuberculosis: a systematic review and meta-analysis","volume":"54","author":"Cohen","journal-title":"Eur Respir J"},{"key":"R22","unstructured":"Namibia. UNAIDS. URL: https:\/\/open.unaids.org\/countries\/namibia [Accessed 31-08-2026]"},{"key":"R23","unstructured":"Botswana. UNAIDS. URL: https:\/\/open.unaids.org\/countries\/botswana [Accessed 31-08-2026]"},{"issue":"3","key":"R24","doi-asserted-by":"publisher","first-page":"264","DOI":"10.5588\/ijtld.17.0491","article-title":"Estimating the magnitude of pulmonary tuberculosis patients missed by primary health care clinics in South Africa","volume":"22","author":"Kweza","journal-title":"Int J Tuberc Lung Dis"},{"issue":"1","key":"R25","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-018-3241-3","article-title":"Preliminary results of official influenza and acute respiratory infection surveillance in two towns of Burkina Faso, 2013-2015","volume":"18","author":"Sagna","journal-title":"BMC Infect Dis"},{"issue":"6","key":"R26","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.3390\/diagnostics12061503","article-title":"COVID-19 diagnosis: a comprehensive review of the RT-qPCR method for detection of SARS-CoV-2","volume":"12","author":"Dutta","journal-title":"Diagnostics (Basel)"},{"key":"R27","doi-asserted-by":"publisher","DOI":"10.1016\/j.mex.2024.102596","article-title":"An efficient ELISA protocol for measurement of SARS-CoV-2 spike-specific IgG in human plasma and serum samples","volume":"12","author":"Appeltrath","journal-title":"MethodsX"},{"key":"R28","unstructured":"SARS-CoV-2 (COVID-19). ARTIC. URL: https:\/\/artic.network\/viruses\/sars-cov-2 [Accessed 23-01-2026]"},{"key":"R29","unstructured":"Jerving S . South Africa data shows higher COVID-19 death rates for people with HIV, TB. Devex. 2020. URL: https:\/\/www.devex.com\/news\/south-africa-data-shows-higher-covid-19-death-rates-for-people-with-hiv-tb-97447 [Accessed 23-01-2026]"},{"issue":"6","key":"R30","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.26104","article-title":"COVID-19 among adults living with HIV: correlates of mortality among public sector healthcare users in Western Cape, South Africa","volume":"26","author":"Kassanjee","journal-title":"J Int AIDS Soc"},{"issue":"2","key":"R31","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3390\/epidemiologia3020023","article-title":"How the COVID-19 pandemic alters the landscapes of the HIV and tuberculosis epidemics in South Africa: a case study and future directions","volume":"3","author":"Eike","journal-title":"Epidemiologia (Basel)"},{"issue":"9","key":"R32","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/S2213-2600(20)30311-8","article-title":"How COVID-19 could benefit tuberculosis and HIV services in South Africa","volume":"8","author":"Keene","journal-title":"Lancet Respir Med"},{"key":"R33","unstructured":"Household transmission investigation protocol for 2019-novel coronavirus (COVID-19) infection. World Health Organization. 2020. URL: https:\/\/www.who.int\/publications\/i\/item\/household-transmission-investigation-protocol-for-2019-novel-coronavirus-(2019-ncov)-infection [Accessed 02-01-2026]"}],"container-title":["JMIR Research Protocols"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T20:52:00Z","timestamp":1789505520000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchprotocols.org\/2026\/1\/e79438"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,15]]},"references-count":33,"URL":"https:\/\/doi.org\/10.2196\/79438","relation":{},"ISSN":["1929-0748"],"issn-type":[{"value":"1929-0748","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,15]]},"article-number":"v15i12e79438"}}